Lisiane Conte Selected Research

norbixin

1/2020	Dietary supplementation with annatto food-coloring extracts increases the resistance of human erythrocytes to hemolysis.
1/2019	Short-Term Bixin Supplementation of Healthy Subjects Decreases the Susceptibility of LDL to Cu2+-Induced Oxidation Ex Vivo.
1/2014	Bixin and norbixin have opposite effects on glycemia, lipidemia, and oxidative stress in streptozotocin-induced diabetic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisiane Conte Research Topics

Disease

3	Body Weight (Weight, Body) 01/2020 - 05/2015
2	Dyslipidemias (Dyslipidemia) 01/2018 - 05/2015
1	Hemolysis 01/2020
1	Atherosclerosis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Hypertrophy 01/2018
1	Hypercholesterolemia 05/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2014

Drug/Important Bio-Agent (IBA)

4	bixinIBA 01/2020 - 01/2014
3	norbixinIBA 01/2020 - 01/2014
2	Carotenoids (Carotene)IBA 01/2020 - 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	2,2'-azobis(2-amidinopropane) (ABAP)IBA 01/2020
1	annattoIBA 01/2020
1	Capsules (Microcapsules)IBA 01/2020
1	Sodium NitriteIBA 01/2020
1	LycopeneIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	EnzymesIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	PowdersIBA 01/2018
1	Hydro-Lyases (Dehydratases)IBA 01/2018
1	AcidsIBA 01/2018
1	Sulfhydryl Compounds (Thiols)IBA 01/2018
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2018
1	DisulfidesIBA 01/2018
1	Simvastatin (Zocor)FDA LinkGeneric 05/2015
1	CholesterolIBA 05/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2014

Therapy/Procedure

1	Aftercare (After-Treatment) 05/2015